3Butenas S,Orfeo T,Kathleen E,et al. Tissue factor in throm-bosis and hemorrhage, Surgery, 2007,142 : S2-S14.
4Maquelin KN, Nieuwland R, Lentjes M. et al. Aprotinin administration in the pericardial cavity does not prevent platelet fletivation, J Thorac Cardiovase Surg, 2000,120 : 552 557,
5Gonzaleza F,Rotea NS,Miniuma J,et al.Elevated circulating tiasue factor levels in polycystic ovary syndrome(PCOS)-relationship with insulin sensitivity,abdominal adiposity and hyperandrogenism,Fertil Steril.2008,90:S15.
6del Conde 1,Kleiman NS,Effect of caffeine on platelet inhibition by clopidogrel in healthy subjects and patients with coronary artery disease,Am Heart J,2007,154:694-699.
7MattiasB,Michael ID,Staffan S,et al.Regulation of angiogenesls by tissue factor cytoplasmic domain signaling.Nat Med,2004,10:502-509.
10Lawes CM.Bennett DA.Parag V,et al.Blood pressure indices and cariovascular disease in the Asia Pacific region:a pooled analysis.Hypertension.2003,42:69-75.
8Gregory YH, Lip MD, Andrew D, et al. Does hypertension confer a prothrombotic state[J]. Circulation, 2000,101(1):218-220.
9Gregory YH, Andrew D, Blann D, et al. Prothrombotic factors,endothelial function and left ventricular hypertrophy in isolated systolic hypertension compared with systolic-diastolic hypertension[J].J Hypertens,1999,17(8):1203-1207.
10Sandet PM, Abildgaard U, Putersen MJ. A sensitive assay of extrinsic coagulation pathway inhibitor in plasma and plasma fraction[J]. Thromb Res,1987,47(2):389-400.
2Milliez P,Girerd X, Plouin PF, et al. Evidence for an increased rate of cardiovascular events in patients with primary aldoste- ronism. J Am Coll Cardiol, 2005,45: 1243-1248.
3Huang M, Gai X, Yang X, et al. Functional polymorphiarns in ACE and CYP11B2 genes and atrial fibrillation in patients with hypertensive heart disease. Clln Chem Lab Med, 2009,47: 32- 37.
4Amir O, Amir RE, Paz H, et al. Aldosterone synthase gene polymorphism as a determinant of atrial fibrillation in patients with heart failure. Am J Cardiol, 2008,102 : 326-329.
